Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Depression Therapy
Estrogen augmentation of antidepressants in perimenopausal depression examined
September 8th, 2005
Estrogen augmentation of antidepressants in perimenopausal depression was recently examined. Researchers in the United States conducted a study "To investigate the effects of estrogen augmentation on mood and memory in women with perimenopausal depression who had experienced a partial response to antidepressant medications. In a double-blind, placebo-controlled trial, 17 subjects taking antidepressant medication were randomly assigned to either 0.625 mg/day of conjugated estrogen (N=11) or matching placebo (N=6) for 6 weeks." "Women between the ages of 40 and 60 years with DSM-IV major depressive disorder (MDD) in partial remission who had been...
Source: Women's Health Weekly (2005-09-08)
|
